Key HighlightsDell Technologies (NYSE:DELL) rose about 11.8% to roughly USD 373.68 on November 11, 2026, among the strongest large-cap technology gainers of the session.Seagate Technology gained about 10% to roughly USD 551.72, as storage stocks rallied alongside memory makers.The rally followed a strongQuarterly Reportfrom …
The Rationale: Last Reported Quarter and Management Outlook for Beasley Broadcast Group (NASDAQ:BBGI)
On August 5, 2026 the company announced a prioritization that ended internal development of CT-95, a mesothelin-targeting engager, and is winding down its Phase 1 trial. The filing says it does not expect material future costs there, and the third-quarter figures include estimated close-out …
Shares of Coherent (NYSE:COHR) had additional support. Reports that Microsoft was lobbying against a proposed US plan to ban new Chinese-made optical transceivers highlighted the debate over supply, and Coherent is one of the US-based manufacturers that couldFillany gap if such restrictions are introduced. …
Hemab develops antibody therapies for blood coagulation disorders. Its lead asset, sutacimig, is a bispecific antibody now in Phase 3 for Glanzmann thrombasthenia. SOLARA is a single-arm study with a 24-week run-in, then 48 weeks of once-weekly subcutaneous dosing, so each participant acts as …
Second quarter 2026 revenue of USD 16.2 million was the sixth consecutive quarter of sequential growth, according to the company. GrossMarginwas about 18.6%, with some segments showing negative margins, and operating income improved by USD 10.3 million from a loss of USD 6.8 million. …
Key HighlightsCorning (NYSE:GLW) closed up 7.43% on November 11, 2026, after a majorInvestmentbank initiated coverage with a Buy rating and a USD 134 price target.The bank argued that AI data centers are driving a shortage of optical fiber, supported by multi-yearSupplycontracts with hyperscalers and …
A going concern note means management's projections show cash will not cover operations for more than one year after the financial statements were issued. The company said it does not expect that USD 35.8 million to last that long and will need substantial additional …
The Rationale: Last Reported Quarter and Management Outlook for Vistagen Therapeutics, Inc. (NASDAQ:VTGN)
The most notable part of the call was the market share forecast. The bank expects Teradyne's share of system-on-chip testing to rise from roughly 27% toward 34% by 2030. Two forces support that view. First, large chip buyers increasingly insist on dual sourcing to …